Financhill
Sell
42

BPMC Quote, Financials, Valuation and Earnings

Last price:
$110.07
Seasonality move :
4.12%
Day range:
$103.67 - $106.49
52-week range:
$72.24 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.01x
P/B ratio:
21.09x
Volume:
753K
Avg. volume:
732.4K
1-year change:
29.1%
Market cap:
$6.6B
Revenue:
$249.4M
EPS (TTM):
-$2.11

Earnings Data

Next earnings date for BPMC
Feb 14
2025
Most recent earnings per share
-$0.89
Beat by $0.07
(Oct 30/2024)
Consensus Estimate
-$0.96
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BPMC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $156.6M -- -- -$0.57 --
02/14/2025 Q4 $145.5M -- -- -$0.69 --
10/30/2024 Q3 $127.5M $128.2M -$0.89 -$0.96 $0.07
08/01/2024 Q2 $103.9M $138.2M -$0.80 -$1.25 $0.45
05/02/2024 Q1 $81.4M $96.1M $1.40 -$1.67 $3.07
02/15/2024 Q4 $67.1M $72M -$1.82 -$2.06 $0.24
10/26/2023 Q3 -- -- -$2.20 -$2.33 $0.13
08/02/2023 Q2 -- -- -$2.19 -$2.49 $0.30
05/04/2023 Q1 -- -- -$2.15 -$2.62 $0.47
02/16/2023 Q4 -- -- -$2.65 -$2.61 -$0.04
11/01/2022 Q3 -- -- -$2.23 -$2.49 $0.26
08/02/2022 Q2 -- -- -$2.68 -$2.26 -$0.42
05/03/2022 Q1 -- -- -$1.79 -$1.85 $0.06
02/16/2022 Q4 -- -- -$5.40 -$1.57 -$3.83
10/28/2021 Q3 -- -- -$2.00 -$1.66 -$0.34
07/29/2021 Q2 -- -- -$1.86 -$1.92 $0.05
04/29/2021 Q1 -- -- -$1.72 -$1.82 $0.10
02/17/2021 Q4 -- -- -$1.53 -$1.55 $0.02
10/29/2020 Q3 -- -- $11.16 $9.30 $1.86
07/30/2020 Q2 -- -- -$2.28 -$2.08 -$0.20
05/06/2020 Q1 -- -- -$2.11 -$2.01 -$0.10
02/13/2020 Q4 -- -- -$1.35 -$1.73 $0.38
11/05/2019 Q3 -- -- -$1.93 -$2.17 $0.24
08/01/2019 Q2 -- -- -- -$1.90 --
05/09/2019 Q1 -- -- -- -$1.89 --
02/26/2019 Q4 -- -- -- -$1.72 --
10/30/2018 Q3 -- -- -- -$1.61 --
08/01/2018 Q2 -- -- -- -- --
05/02/2018 Q1 -- -- -- -- --
02/21/2018 Q4 -- -- -- -- --
10/31/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
05/09/2017 Q1 -- -- -- -- --
03/09/2017 Q4 -- -- -- -- --
11/10/2016 Q3 -- -- -- -- --
08/09/2016 Q2 -- -- -- -- --
05/10/2016 Q1 -- -- -- -- --
03/14/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --
09/10/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --

Blueprint Medicines Earnings Questions

  • How Much did Blueprint Medicines Generate in Revenue Last Quarter?

    Blueprint Medicines reported $128.2M worth of top line sales in its most recent quarter.

  • Did Blueprint Medicines Beat Earnings Last Quarter?

    Blueprint Medicines announced earnings per share of -$0.89 which represents a beat of analyst forecast a -$0.96 per share.

  • Is Blueprint Medicines Profitable?

    Blueprint Medicines reported $126.3M that represents $1.99 per share over the last quarter.

  • What is the Analyst Consensus for Blueprint Medicines EPS Next Year?

    Blueprint Medicines's earnings are forecast to decrease from -$8.37 per share to -$1.33 per share next year representing a decrease of -82.94%.

  • When is Blueprint Medicines's Earnings Date?

    Blueprint Medicines's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Cigna vs Costco Stock: Which Is Best?
Cigna vs Costco Stock: Which Is Best?

Cigna and Costco don’t usually go hand in hand but…

Will T-Mobile Stock Recover?
Will T-Mobile Stock Recover?

Last year was a stellar year for telecom giant T-Mobile…

Why Is Stanley Druckenmiller Buying Citigroup?
Why Is Stanley Druckenmiller Buying Citigroup?

As recently as 2020, few analysts could have predicted that…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 112x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
40
NUKK alert for Jan 17

Nukkleus [NUKK] is up 45.98% over the past day.

Sell
45
NUTX alert for Jan 17

Nutex Health [NUTX] is up 2.83% over the past day.

Buy
53
QMCO alert for Jan 17

Quantum [QMCO] is down 15.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock